Tiragolumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Tiragolumab is a monoclonal antibody that targets the inhibitory receptor T-cell immunoglobulin and ITIM domain (TIGIT), which is expressed on lymphocytes and suppresses the immune response to cancer.

Tiragolumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Tiragolumab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	32161	58
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	57505	58
ShangHai Biochempartner Co.,Ltd	17754423994 17754423994	2853530910@QQ.com	China	8011	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1566	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10436	58
Bide Pharmatech Ltd.	400-1647117 13681763483	product02@bidepharm.com	China	62075	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24644	58
Biolab Reagents	027-65279366 18108604862	products@biolabreagent.com	China	9818	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	orders@jknbiochem.com	China	5822	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11974	58

---

• Tiragolumab
• Research Grade Tiragolumab(DHH72401)
• Tiragolumab (anti-TIGIT)
• RO 7092284|||RG6058-10|||MTIG-7192A|||RG6058-11|||RG-6058
• 1918185-84-8